LexDanaLexDanabeta
Inventor

Anders Pettersson

Inventor
Kode, SE

Overview

30→
Patents
1999–2019
Patent span
Human necessities
Primary field (CPC A)

Patents· 30 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes34%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
A61BDiagnosis3%
G06FElectric digital data processing3%
H04LTransmission of digital information, e.g. telegraphic communication3%
A23BPreservation of foods, foodstuffs or non-alcoholic beverages1%
A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or propionic acid bacteria used in foodstuffs or food preparation1%
A61CDentistry1%
A61FFilters implantable into blood vessels1%
A61LMethods or apparatus for sterilising materials or objects in general1%
PatentTitleYear
10,251,834Transdermal drug administration device20199,782,396'Alfentanil composition for the treatment of acute pain'20179,597,281'Pharmaceutical formulations useful in the treatment of insomnia'20179,384,529'Flight data display'20169,345,698'Alfentanil composition for the treatment of acute pain'20169,265,720'Pharmaceutical formulations useful in the treatment of insomnia'20169,172,589'Method for configuring a distributed avionics control system'20158,980,305'Non-abusable pharmaceutical composition comprising opioids'20158,821,914'Non-abusable pharmaceutical composition comprising opioids'20148,815,911'Alfentanil composition for the treatment of acute pain'20148,658,198'Non-abusable pharmaceutical composition comprising opioids'20148,543,263'Distributed avionics'20138,512,747'Pharmaceutical composition for the treatment of acute disorders'20138,470,361'Non-abusable pharmaceutical composition comprising opioids'20138,454,996'Pharmaceutical composition for the treatment of acute disorders'20138,400,796'Power converter with distributed cell control'20138,391,958'Method and arrangement relating to testing objects'20137,910,132'Pharmaceutical composition for the treatment of acute disorders'20117,815,940'Gastric acid secretion inhibiting composition'20107,785,626'Gastric acid secretion inhibiting composition'20107,771,747'Gastric acid secretion inhibiting composition'20107,449,205'Banana coating for enhanced quality on storage and shipping'20086,962,687'Method and means for detecting inflammatory processes'20056,761,910'Pharmaceutical composition for the treatment of acute disorders'20046,759,059'Fentanyl composition for the treatment of acute pain'20046,113,875'Diagnostic preparation for detection of helicobacter pylori'20006,096,772'Use of Angiotensin II type 1 receptor antagonists in the treatment of dyspeptic symptoms'20006,083,756'Prevention of sudden infant death'20005,977,159'Medical use of an ace-inhibitor for treatment of dyspeptic symptoms'19995,900,428'Pharmacological use of AII-receptor antagonists'1999

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1999–2000Patents assigned to ASTRA AB (3)· patent assignee history
1999–2017Based in Kode, SE· patent location history
2000–2004Patents assigned to DIABACT AB (4)· patent assignee history
2005–2017Patents assigned to OREXO AB (15)· patent assignee history
2010Based in Lilla Edet, SE· patent location history
2013–2019Patents assigned to PETTERSSON ANDERS (9)· patent assignee history
2013–2016Patents assigned to DANIELSSON TORKEL (3)· patent assignee history
2013–2019Based in Uppsala, SE· patent location history
2013–2016Based in Linköping, SE· patent location history
2015Based in Linkoping, SE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
OREXO AB152005–2017
PETTERSSON ANDERSself92013–2019
DIABACT AB42000–2004
ASTRA AB31999–2000
DANIELSSON TORKEL32013–2016
Locations
LocationPatentsSpan
Kode, SE201999–2017
Uppsala, SE22013–2019
Linköping, SE22013–2016
Lilla Edet, SE22010
Linkoping, SE12015